Clinical trial
A Study to Evaluate the Safety and Efficacy of Adding Enfuvirtide to Oral Highly…
NCT00487188 · Hoffmann-La Roche, Industry · Completed
Key facts
| NCT number | NCT00487188 |
|---|---|
| Title | A Study to Evaluate the Safety and Efficacy of Adding Enfuvirtide to Oral Highly Active Antiretroviral Therapy (HAART) in Human Immunodeficiency Virus (HIV) Patients With Prior Treatment Experience |
| Official title | Phase IIIb/IV Randomized, Controlled Study Evaluating an Intensification Treatment Strategy of Adding Enfuvirtide (ENF) to an Oral Highly Active AntiRetroviral Therapy (HAART) in Treatment Experienced Patients |
| Acronym | INTENSE |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Enfuvirtide, Highly active antiretroviral treatment (HAART) |
| Enrollment | 47 |
| Start date | Nov 1, 2005 |
| Primary completion | Nov 1, 2007 |
| Completion | Apr 1, 2008 |
| First posted | Jun 15, 2007 |
| Last update posted | Aug 13, 2015 |
| Countries | Canada, France, Germany, Israel, Italy, Mexico, Netherlands, Spain, Switzerland, United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: